Elangovan H et al. recently published a review summarizing the role of vitamin D in liver diseases, with a particular focus on vitamin D supplementation in hepatopathies. In the section on Clinical studies in non-alcoholic fatty liver disease (6.3), among others, the authors commented the monocentric, randomized, double blind, placebo controlled trial which we conducted on 55 patients with type 2 diabetes and NAFLD (number 2011-003010-17, www.clinicaltrialsregister.eu) at Sapienza University of Rome, Italy.
Comment on Elangovan H et al. Vitamin D in liver disease: Current evidence and potential directions. Biochim Biophys Acta 2017;1863(4):907-916 / Barchetta, I., DEL BEN, M., Angelico, F., DI MARTINO, M., Fraioli, A., LA TORRE, G., Saulle, R., Perri, L., Morini, S., Tiberti, C., Bertoccini, L., Cimini, F.A., Panimolle, F., Catalano, C., Baroni, M.G., Cavallo, M.G.. - In: BIOCHIMICA ET BIOPHYSICA ACTA. - ISSN 0006-3002. - 1863:9(2017). [10.1016/j.bbadis.2017.04.023]
Comment on Elangovan H et al. Vitamin D in liver disease: Current evidence and potential directions. Biochim Biophys Acta 2017;1863(4):907-916
BARCHETTA, ILARIAPrimo
;DEL BEN, MariaSecondo
;ANGELICO, Francesco;DI MARTINO, MICHELE;FRAIOLI, Antonio;LA TORRE, Giuseppe;SAULLE, ROSELLA;TIBERTI, Claudio;BERTOCCINI, LAURA;PANIMOLLE, FRANCESCA;CATALANO, Carlo;BARONI, Marco GiorgioPenultimo
;CAVALLO, Maria GisellaUltimo
2017
Abstract
Elangovan H et al. recently published a review summarizing the role of vitamin D in liver diseases, with a particular focus on vitamin D supplementation in hepatopathies. In the section on Clinical studies in non-alcoholic fatty liver disease (6.3), among others, the authors commented the monocentric, randomized, double blind, placebo controlled trial which we conducted on 55 patients with type 2 diabetes and NAFLD (number 2011-003010-17, www.clinicaltrialsregister.eu) at Sapienza University of Rome, Italy.| File | Dimensione | Formato | |
|---|---|---|---|
|
Barchetta_Comment-on-Elangovan-H_2017.pdf
solo gestori archivio
Note: Comment on Elangovan H et al. Vitamin D in liver disease- Current evidence and potential directions. Biochim Biophys Acta 2017
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Altra licenza (allegare)
Dimensione
100.85 kB
Formato
Adobe PDF
|
100.85 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
